12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

I-124-CLR1404: Phase I/II started

Novelos began an open-label, U.S. Phase I/II trial to evaluate I-124-CLR1404 (LIGHT) in PET imaging in about 81 patients with advanced solid tumors, including soft tissue...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >